Cargando…
Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort
BACKGROUND: Recent evidence identified exposure to particulate matter of size ≤2.5 µm (PM(2.5)) as a risk factor for high prevalence of small airway dysfunction (SAD). We assessed the prevalence of SAD in a European region with low air pollution levels. METHODS: SAD was defined as a maximum mid-expi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493711/ https://www.ncbi.nlm.nih.gov/pubmed/37701366 http://dx.doi.org/10.1183/23120541.00381-2023 |
_version_ | 1785104538836926464 |
---|---|
author | Touilloux, Brice Bongard, Cedric Lechartier, Benoit Truong, Minh Khoa Marques-Vidal, Pedro Vollenweider, Peter Vaucher, Julien Casutt, Alessio von Garnier, Christophe |
author_facet | Touilloux, Brice Bongard, Cedric Lechartier, Benoit Truong, Minh Khoa Marques-Vidal, Pedro Vollenweider, Peter Vaucher, Julien Casutt, Alessio von Garnier, Christophe |
author_sort | Touilloux, Brice |
collection | PubMed |
description | BACKGROUND: Recent evidence identified exposure to particulate matter of size ≤2.5 µm (PM(2.5)) as a risk factor for high prevalence of small airway dysfunction (SAD). We assessed the prevalence of SAD in a European region with low air pollution levels. METHODS: SAD was defined as a maximum mid-expiratory flow (MMEF) <65% of predicted value (PV) or MMEF <lower limit of normal (LLN) measured by spirometry in the Swiss PneumoLaus cohort. We performed bivariate and multivariable analysis with MMEF criteria, age, sex, body mass index, respiratory symptoms and smoking status. Mean PM(2.5) values were obtained from a Swiss national database. RESULTS: Among 3351 participants (97.6% Caucasian, 55.7% female sex, mean age 62.7 years), we observed MMEF <65% PV in 425 (12.7%) and MMEF <LLN in 167 (5.0%) individuals. None of the participants had both MMEF <LLN and ≥65% PV. MMEF <65% PV and MMEF <LLN were significantly associated with age, smoking status, cough, sputum and dyspnoea, whereas a positive association with MMEF <65% PV was observed for individuals aged >65 years only. In an area where ambient PM(2.5) concentration was <15 µg·m(−3) during the observation period (2010 and 2020), ≥72% of participants with SAD were ever-smokers. CONCLUSIONS: The observed low prevalence of SAD of 5.0–12.7% depending on criteria employed may be related to lower PM(2.5) exposure. Smoking was the main factor associated with SAD in an area with low PM(2.5) exposure. Employing a MMEF threshold <65% PV carries a risk of SAD overdiagnosis in elderly individuals. |
format | Online Article Text |
id | pubmed-10493711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104937112023-09-12 Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort Touilloux, Brice Bongard, Cedric Lechartier, Benoit Truong, Minh Khoa Marques-Vidal, Pedro Vollenweider, Peter Vaucher, Julien Casutt, Alessio von Garnier, Christophe ERJ Open Res Original Research Articles BACKGROUND: Recent evidence identified exposure to particulate matter of size ≤2.5 µm (PM(2.5)) as a risk factor for high prevalence of small airway dysfunction (SAD). We assessed the prevalence of SAD in a European region with low air pollution levels. METHODS: SAD was defined as a maximum mid-expiratory flow (MMEF) <65% of predicted value (PV) or MMEF <lower limit of normal (LLN) measured by spirometry in the Swiss PneumoLaus cohort. We performed bivariate and multivariable analysis with MMEF criteria, age, sex, body mass index, respiratory symptoms and smoking status. Mean PM(2.5) values were obtained from a Swiss national database. RESULTS: Among 3351 participants (97.6% Caucasian, 55.7% female sex, mean age 62.7 years), we observed MMEF <65% PV in 425 (12.7%) and MMEF <LLN in 167 (5.0%) individuals. None of the participants had both MMEF <LLN and ≥65% PV. MMEF <65% PV and MMEF <LLN were significantly associated with age, smoking status, cough, sputum and dyspnoea, whereas a positive association with MMEF <65% PV was observed for individuals aged >65 years only. In an area where ambient PM(2.5) concentration was <15 µg·m(−3) during the observation period (2010 and 2020), ≥72% of participants with SAD were ever-smokers. CONCLUSIONS: The observed low prevalence of SAD of 5.0–12.7% depending on criteria employed may be related to lower PM(2.5) exposure. Smoking was the main factor associated with SAD in an area with low PM(2.5) exposure. Employing a MMEF threshold <65% PV carries a risk of SAD overdiagnosis in elderly individuals. European Respiratory Society 2023-09-11 /pmc/articles/PMC10493711/ /pubmed/37701366 http://dx.doi.org/10.1183/23120541.00381-2023 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Original Research Articles Touilloux, Brice Bongard, Cedric Lechartier, Benoit Truong, Minh Khoa Marques-Vidal, Pedro Vollenweider, Peter Vaucher, Julien Casutt, Alessio von Garnier, Christophe Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort |
title | Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort |
title_full | Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort |
title_fullStr | Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort |
title_full_unstemmed | Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort |
title_short | Prevalence of small airway dysfunction in the Swiss PneumoLaus Cohort |
title_sort | prevalence of small airway dysfunction in the swiss pneumolaus cohort |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493711/ https://www.ncbi.nlm.nih.gov/pubmed/37701366 http://dx.doi.org/10.1183/23120541.00381-2023 |
work_keys_str_mv | AT touillouxbrice prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT bongardcedric prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT lechartierbenoit prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT truongminhkhoa prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT marquesvidalpedro prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT vollenweiderpeter prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT vaucherjulien prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT casuttalessio prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort AT vongarnierchristophe prevalenceofsmallairwaydysfunctionintheswisspneumolauscohort |